Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scopolamine induced learning failures in man.

R C Petersen

    Psychopharmacology
    |May 9, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Scopolamine primarily impairs the acquisition of new memories, not the retrieval of existing ones. This study investigated its effects on human memory functions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Donanemab: Appropriate use recommendations.

    The journal of prevention of Alzheimer's disease·2025
    Same author

    Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.

    The journal of prevention of Alzheimer's disease·2024
    Same author

    Continuous Associations between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer's Disease.

    The journal of prevention of Alzheimer's disease..·2024
    Same author

    A Pragmatic, Investigator-Driven Process for Disclosure of Amyloid PET Scan Results to ADNI-4 Research Participants.

    The journal of prevention of Alzheimer's disease·2024
    Same author

    Lecanemab: Appropriate Use Recommendations.

    The journal of prevention of Alzheimer's disease·2023
    Same author

    Alzheimer's Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer's Clinical Trial Consortium Sites.

    The journal of prevention of Alzheimer's disease·2022
    Same journal

    Sotagliflozin pretreatment attenuates acute LPS-induced depression-like behavioral abnormalities and modulates the gut microbiota-immune-brain axis.

    Psychopharmacology·2026
    Same journal

    GlyT1 inhibition enhances working memory in the mouse TUNL task and normalizes NMDA antagonist-induced network activity.

    Psychopharmacology·2026
    Same journal

    Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in mice.

    Psychopharmacology·2026
    Same journal

    Cannabidiol in the anterior insular cortex attenuates chronic neuropathic pain and comorbid anxiety- and depression-like behaviors: involvement of CB<sub>1</sub> and 5-HT<sub>1A</sub> receptor signaling.

    Psychopharmacology·2026
    Same journal

    Fentanyl decreases arterial blood oxygen saturation more than furanylfentanyl in mice due to increased apnea.

    Psychopharmacology·2026
    Same journal

    Suicide attempt risk among patients receiving methylphenidate: a retrospective cohort study.

    Psychopharmacology·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Cognitive Psychology
    • Pharmacology

    Background:

    • Scopolamine is a known cognitive enhancer and a muscarinic receptor antagonist.
    • Its precise effects on different memory processes (acquisition, retention, retrieval) require further elucidation.

    Purpose of the Study:

    • To determine the specific locus of scopolamine's amnestic effects in humans.
    • To differentiate the impact of scopolamine on memory acquisition versus memory retrieval.

    Main Methods:

    • Two experiments involving human volunteers administered varying doses of scopolamine intravenously.
    • Assessment of memory functions including pre-drug learning retention, in-drug learning acquisition, and post-drug retention.
    • Verbal material learning and recall tests conducted at different intervals up to 24 hours.

    Related Experiment Videos

    Main Results:

    • Scopolamine significantly impaired the acquisition of new information.
    • The drug had a lesser effect on the retrieval of previously learned material.
    • Results were consistent across both experiments, confirming the primary impact on new memory formation.

    Conclusions:

    • Scopolamine's main effect on human memory is through the impairment of new information acquisition.
    • These findings provide insights into the neurobiological mechanisms underlying memory formation and the effects of cholinergic blockade.